Discoveries in Medicine - Vanderbilt Health Update

Jan 23

Written By Bruce Melancon

More on our ongoing collaboration with W. David Merryman, Walters Family Professor of Biomedical Engineering at VU, on addressing pulmonary arterial hypertension (PAH) using peripherally restricted 5-HT2B antagonists. Discoveries in Medicine - Antagonist of Serotonin 2B Blunts Heart and PAH Remodeling (vanderbilthealth.com)

#collaboration#drugdiscovery#biotech#WCNDD

Bruce Melancon

CAS Life Sciences Advisory Board

Lindsley named 2022 fellow of American Society for Pharmacology and Experimental Therapeutics